| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | 16-beta-bromoandrosterone | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.002 | 1 |
| mRNA | AZD0530 | FIMM | pan-cancer | AAC | -0.0089 | 1 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.0095 | 1 |
| mRNA | CHM-1 | CTRPv2 | pan-cancer | AAC | 0.0017 | 1 |
| mRNA | MLN4924 | CTRPv2 | pan-cancer | AAC | -0.0018 | 1 |
| mRNA | Mitomycin-C | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | parbendazole | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |